Merrilee Needham

6.1k total citations
112 papers, 2.5k citations indexed

About

Merrilee Needham is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Merrilee Needham has authored 112 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 27 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in Merrilee Needham's work include Inflammatory Myopathies and Dermatomyositis (68 papers), Immunodeficiency and Autoimmune Disorders (16 papers) and Eosinophilic Disorders and Syndromes (16 papers). Merrilee Needham is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (68 papers), Immunodeficiency and Autoimmune Disorders (16 papers) and Eosinophilic Disorders and Syndromes (16 papers). Merrilee Needham collaborates with scholars based in Australia, United States and Netherlands. Merrilee Needham's co-authors include Frank Mastaglia, Francis Mastaglia, Christina Liang, Alastair Corbett, Timothy Day, P. J. Zilko, Thomas E. Lloyd, Victoria A. Fabian, Wally Knezevic and Peter K. Panegyres and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Merrilee Needham

106 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merrilee Needham Australia 29 1.5k 859 598 516 410 112 2.5k
Josep M. Grau‐Junyent Spain 19 1.1k 0.7× 407 0.5× 550 0.9× 267 0.5× 102 0.2× 43 1.6k
Anthony A. Amato United States 21 650 0.4× 414 0.5× 317 0.5× 695 1.3× 152 0.4× 41 1.7k
Thomas H. Brannagan United States 33 447 0.3× 900 1.0× 257 0.4× 1.8k 3.5× 262 0.6× 117 3.6k
Glenn D. Sandberg United States 15 367 0.2× 235 0.3× 395 0.7× 531 1.0× 236 0.6× 30 1.8k
Michelle L. Mauermann United States 27 295 0.2× 740 0.9× 209 0.3× 1.4k 2.7× 394 1.0× 114 2.8k
Ning Lin United States 31 542 0.4× 460 0.5× 346 0.6× 1.6k 3.0× 283 0.7× 124 3.0k
Brian R. Younge United States 33 420 0.3× 348 0.4× 1.2k 2.0× 753 1.5× 506 1.2× 62 3.8k
Wolfgang Saeger Germany 41 1.4k 1.0× 1.3k 1.5× 311 0.5× 689 1.3× 1.5k 3.7× 304 6.6k
Shinsuke Suzuki Japan 26 278 0.2× 617 0.7× 345 0.6× 451 0.9× 79 0.2× 141 2.5k
Maya Lodish United States 34 495 0.3× 1.0k 1.2× 127 0.2× 572 1.1× 336 0.8× 130 3.9k

Countries citing papers authored by Merrilee Needham

Since Specialization
Citations

This map shows the geographic impact of Merrilee Needham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merrilee Needham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrilee Needham more than expected).

Fields of papers citing papers by Merrilee Needham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merrilee Needham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merrilee Needham. The network helps show where Merrilee Needham may publish in the future.

Co-authorship network of co-authors of Merrilee Needham

This figure shows the co-authorship network connecting the top 25 collaborators of Merrilee Needham. A scholar is included among the top collaborators of Merrilee Needham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merrilee Needham. Merrilee Needham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hird, Kathryn, et al.. (2025). Mind over matter? A cross-sectional study exploring the influence of depression versus physical disability on patient-reported wellbeing in inclusion body myositis. SHILAP Revista de lepidopterología. 17. 100199–100199. 1 indexed citations
2.
Mastaglia, Frank, et al.. (2025). Expression and Site-Specific Biotinylation of Human Cytosolic 5′-Nucleotidase 1A in Escherichia coli. Methods and Protocols. 8(3). 66–66.
3.
Limaye, Vidya, Harsha Gunawardena, Ross Sadler, et al.. (2025). The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study. Lara D. Veeken. 64(9). 4995–5003. 1 indexed citations
4.
Cooper, Ian, et al.. (2024). Consumer‐driven evaluation of assistive technology usage and perceived value in people with myositis in Australia. Australian Occupational Therapy Journal. 71(5). 686–698.
6.
Cooper, Ian, et al.. (2024). Prevalence of urinary and bowel incontinence among individuals with myositis: A cross-sectional study. SHILAP Revista de lepidopterología. 11. 101319–101319. 1 indexed citations
7.
Saygın, Didem, Victoria P. Werth, Julie J. Paik, et al.. (2024). Response to: Correspondence on ‘Current myositis clinical trials and tribulations’ by Saygin et al. Annals of the Rheumatic Diseases. 83(11). e23–e23. 1 indexed citations
8.
Saygın, Didem, Helene Alexanderson, Dana DiRenzo, et al.. (2024). The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism. 67. 152476–152476. 2 indexed citations
9.
Eijk, Ruben P. A. van, Matthew C. Kiernan, Allan F. McRae, et al.. (2024). Amyotrophic lateral sclerosis established as a multistep process across phenotypes. European Journal of Neurology. 32(1). e16532–e16532. 2 indexed citations
10.
Cooper, Ian, et al.. (2024). Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models. Clinical & Translational Immunology. 13(4). e1504–e1504. 4 indexed citations
12.
Saygın, Didem, Matteo Bottai, Marjolein Visser, et al.. (2023). Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review. Clinical and Experimental Rheumatology. 42(2). 403–412. 4 indexed citations
15.
Hannaford, Andrew, Karen Byth, Nathan Pavey, et al.. (2022). Clinical and neurophysiological biomarkers of disease progression in amyotrophic lateral sclerosis. Muscle & Nerve. 67(1). 17–24. 4 indexed citations
18.
Vucic, Steve, Robert D. Henderson, Susan Mathers, et al.. (2021). Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study. Annals of Clinical and Translational Neurology. 8(10). 1991–1999. 24 indexed citations
20.
Makino, Keishi, et al.. (2015). Quantifying The Cost And Quality Of Life Implications Of Adverse Events Associated With Long-Term Oral Corticosteroid Use. Value in Health. 18(7). A688–A688. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026